Shots: Kite and Kiniksa enter into a clinical collaboration to conduct a P-II study assessing Yescarta + mavrilimumab in patients with r/r LBCL. Kite will sponsor and conduct the study […]readmore
Tags : (axicabtagene ciloleucel)
Shots: The ZUMA-1 trial involves assessing of Yescarta in patients with refractory large B-cell lymphoma for a duration of two years ZUMA-1 trial results (N=101): OR 83%; CR 58%; median […]readmore